CASi-002

N/A

Report date: 2024/12/19 10:37:40
NME

Base Information

Drug NameCASi-002
Drug Alias NameCASi-002
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAnti-TAU
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer DiseaseSupranuclear Palsy, Progressive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSwitch Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSwitch Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseSupranuclear Palsy, Progressive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A